{"id":"https://openalex.org/W4403746293","doi":"https://doi.org/10.1136/ijgc-2024-005497","title":"Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer","display_name":"Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer","publication_year":2024,"publication_date":"2024-10-23","ids":{"openalex":"https://openalex.org/W4403746293","doi":"https://doi.org/10.1136/ijgc-2024-005497","pmid":"https://pubmed.ncbi.nlm.nih.gov/39448084"},"language":"en","primary_location":{"id":"doi:10.1136/ijgc-2024-005497","doi":"https://doi.org/10.1136/ijgc-2024-005497","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2024-005497","pdf_url":null,"source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4403746293"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1136/ijgc-2024-005497","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062635658","display_name":"Jos\u00e9 Alejandro P\u00e9rez Fidalgo","orcid":"https://orcid.org/0000-0003-3568-4345","observed_orcids":["https://orcid.org/0000-0003-3568-4345"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210094406","display_name":"Hospital Cl\u00ednico Universitario de Valencia","ror":"https://ror.org/00hpnj894","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210094406"]},{"id":"https://openalex.org/I4210158373","display_name":"INCLIVA Health Research Institute","ror":"https://ror.org/059wbyv33","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158373"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Alejandro Perez-Fidalgo","raw_affiliation_strings":["INCLIVA, Hospital Clinico Universitario de Valencia, Valencia, Spain; Ciberonc, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: japfidalgo@msn.com","Ciberonc, Instituto de Salud Carlos III, Madrid, Spain","INCLIVA, Hospital Clinico Universitario de Valencia, Valencia, Spain"],"raw_orcid":"https://orcid.org/0000-0003-3568-4345","affiliations":[{"raw_affiliation_string":"INCLIVA, Hospital Clinico Universitario de Valencia, Valencia, Spain; Ciberonc, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: japfidalgo@msn.com","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210094406","https://openalex.org/I4210158373"]},{"raw_affiliation_string":"Ciberonc, Instituto de Salud Carlos III, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]},{"raw_affiliation_string":"INCLIVA, Hospital Clinico Universitario de Valencia, Valencia, Spain","institution_ids":["https://openalex.org/I4210094406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110450109","display_name":"Barbara Schmalfeldt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Barbara Schmalfeldt","raw_affiliation_strings":["Clinic and Polyclinic for Gynaecology, University Hospital Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic and Polyclinic for Gynaecology, University Hospital Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007424793","display_name":"Angela Joy George","orcid":"https://orcid.org/0000-0002-4295-7287","observed_orcids":["https://orcid.org/0000-0002-4295-7287"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Angela George","raw_affiliation_strings":["Genomics and Oncology, Royal Marsden Hospital, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genomics and Oncology, Royal Marsden Hospital, Sutton, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009351129","display_name":"Charlie Gourley","orcid":"https://orcid.org/0000-0002-2377-7221","observed_orcids":["https://orcid.org/0000-0002-2377-7221"]},"institutions":[{"id":"https://openalex.org/I2802581871","display_name":"Edinburgh Cancer Research","ror":"https://ror.org/05a7t9b67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I2802581871","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I4210158898","display_name":"Institute of Genetics and Cancer","ror":"https://ror.org/05hygey35","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210087105","https://openalex.org/I4210158898","https://openalex.org/I90344618","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlie Gourley","raw_affiliation_strings":["CRUK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRUK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK","institution_ids":["https://openalex.org/I2802581871","https://openalex.org/I4210158898","https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083659627","display_name":"Sandro Pignata","orcid":"https://orcid.org/0000-0002-8836-2633","observed_orcids":["https://orcid.org/0000-0002-8836-2633"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sandro Pignata","raw_affiliation_strings":["Istituto Nazionale Tumori di Napoli IRCCS Fondazione G Pascale, Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori di Napoli IRCCS Fondazione G Pascale, Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061939825","display_name":"Domenica Lorusso","orcid":"https://orcid.org/0000-0003-0981-0598","observed_orcids":["https://orcid.org/0000-0003-0981-0598"]},"institutions":[{"id":"https://openalex.org/I1339471597","display_name":"Humanitas University","ror":"https://ror.org/020dggs04","country_code":"IT","type":"education","lineage":["https://openalex.org/I1339471597"]},{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Domenica Lorusso","raw_affiliation_strings":["Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy","Department of Biomedical Sciences, Humanitas University, Milan, Italy","IRCCS Humanitas Research Hospital, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy","institution_ids":["https://openalex.org/I1339471597","https://openalex.org/I4210163047"]},{"raw_affiliation_string":"Department of Biomedical Sciences, Humanitas University, Milan, Italy","institution_ids":["https://openalex.org/I1339471597"]},{"raw_affiliation_string":"IRCCS Humanitas Research Hospital, Milan, Italy","institution_ids":["https://openalex.org/I4210163047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046602099","display_name":"Maria-Pilar Barretina-Ginesta","orcid":"https://orcid.org/0000-0003-0074-6614","observed_orcids":["https://orcid.org/0000-0003-0074-6614"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210113168","display_name":"Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona","ror":"https://ror.org/020yb3m85","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210113168","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Pilar Barretina-Ginesta","raw_affiliation_strings":["Catalan Institute of Oncology Girona, IDIBGI-CERCA, Girona, Spain"],"raw_orcid":"https://orcid.org/0000-0003-0074-6614","affiliations":[{"raw_affiliation_string":"Catalan Institute of Oncology Girona, IDIBGI-CERCA, Girona, Spain","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210113168"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060787566","display_name":"Ignacio Romero","orcid":"https://orcid.org/0000-0001-8622-618X","observed_orcids":["https://orcid.org/0000-0001-8622-618X"]},"institutions":[{"id":"https://openalex.org/I4210103093","display_name":"Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda","ror":"https://ror.org/01fh9k283","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210103093"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ignacio Romero","raw_affiliation_strings":["Instituto Valenciano de Oncolog\u00eda, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Valenciano de Oncolog\u00eda, Valencia, Spain","institution_ids":["https://openalex.org/I4210103093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051069867","display_name":"Christoph Grimm","orcid":"https://orcid.org/0000-0003-2948-8129","observed_orcids":["https://orcid.org/0000-0003-2948-8129"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Christoph Grimm","raw_affiliation_strings":["Gynecologic Cancer Unit, Medical University of Vienna, Vienna, Austria"],"raw_orcid":"https://orcid.org/0000-0003-2948-8129","affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Unit, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080757346","display_name":"Toon Van Gorp","orcid":"https://orcid.org/0000-0002-2564-721X","observed_orcids":["https://orcid.org/0000-0002-2564-721X","https://orcid.org/0000-0002-1573-8716"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Toon Van Gorp","raw_affiliation_strings":["Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-2564-721X","affiliations":[{"raw_affiliation_string":"Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040708282","display_name":"Maria Rossing","orcid":"https://orcid.org/0000-0003-4325-3027","observed_orcids":["https://orcid.org/0000-0003-4325-3027"]},"institutions":[{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Maria Rossing","raw_affiliation_strings":["Center for Genomic Medicine, Diagnostic Center, Rigshospitalet, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Genomic Medicine, Diagnostic Center, Rigshospitalet, Copenhagen, Denmark","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060391756","display_name":"Dearbhaile Catherine Collins","orcid":"https://orcid.org/0000-0002-5156-0142","observed_orcids":["https://orcid.org/0000-0002-5156-0142"]},"institutions":[{"id":"https://openalex.org/I2802396013","display_name":"Cork University Hospital","ror":"https://ror.org/04q107642","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I2802396013"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Dearbhaile C. Collins","raw_affiliation_strings":["CUH/UCC Cancer Centre, Cork University Hospital, Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CUH/UCC Cancer Centre, Cork University Hospital, Cork, Ireland","institution_ids":["https://openalex.org/I2802396013"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108300216","display_name":"Josefin Fernebro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Josefin Fernebro","raw_affiliation_strings":["Section of Gynecological Oncology, Karolinska University Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Gynecological Oncology, Karolinska University Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019754075","display_name":"Line Bj\u00f8rge","orcid":"https://orcid.org/0000-0002-0240-2770","observed_orcids":["https://orcid.org/0000-0002-0240-2770"]},"institutions":[{"id":"https://openalex.org/I2800740805","display_name":"Haukeland University Hospital","ror":"https://ror.org/03np4e098","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I2800740805"]},{"id":"https://openalex.org/I4432739","display_name":"University of Bergen","ror":"https://ror.org/03zga2b32","country_code":"NO","type":"education","lineage":["https://openalex.org/I4432739"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Line Bj\u00f8rge","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, Center for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway","Department of Clinical Science, Center for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway","Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway"],"raw_orcid":"https://orcid.org/0000-0002-0240-2770","affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, Center for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway","institution_ids":["https://openalex.org/I2800740805","https://openalex.org/I4432739"]},{"raw_affiliation_string":"Department of Clinical Science, Center for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway","institution_ids":["https://openalex.org/I4432739"]},{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway","institution_ids":["https://openalex.org/I2800740805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025155327","display_name":"Alexandra F. Leary","orcid":"https://orcid.org/0000-0002-2043-2244","observed_orcids":["https://orcid.org/0000-0002-2043-2244"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alexandra Leary","raw_affiliation_strings":["Department of Adult Medicine, Institut de Cancerologie Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Adult Medicine, Institut de Cancerologie Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084631227","display_name":"Thibault De La Motte Rouge","orcid":"https://orcid.org/0000-0002-0088-6003","observed_orcids":["https://orcid.org/0000-0002-0088-6003"]},"institutions":[{"id":"https://openalex.org/I4210110881","display_name":"Centre Eug\u00e8ne Marquis","ror":"https://ror.org/01yezas83","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210110881"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Thibault de la Motte Rouge","raw_affiliation_strings":["Centre Eug\u00e8ne Marquis, Rennes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Eug\u00e8ne Marquis, Rennes, France","institution_ids":["https://openalex.org/I4210110881"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078567055","display_name":"Philipp Harter","orcid":"https://orcid.org/0000-0002-9663-5005","observed_orcids":["https://orcid.org/0000-0002-9663-5005"]},"institutions":[{"id":"https://openalex.org/I4210146447","display_name":"Kliniken Essen-Mitte","ror":"https://ror.org/03v958f45","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210146447"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Philipp Harter","raw_affiliation_strings":["Kliniken Essen-Mitte, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kliniken Essen-Mitte, Essen, Germany","institution_ids":["https://openalex.org/I4210146447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103276402","display_name":"Christian Kurzeder","orcid":"https://orcid.org/0000-0003-4368-7490","observed_orcids":["https://orcid.org/0000-0003-4368-7490"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Christian Kurzeder","raw_affiliation_strings":["University Hospital Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028744806","display_name":"Joana Savva-Bordalo","orcid":"https://orcid.org/0000-0002-9585-7474","observed_orcids":["https://orcid.org/0000-0002-9585-7474"]},"institutions":[{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Joana Savva-Bordalo","raw_affiliation_strings":["Portuguese Institute of Oncology, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Portuguese Institute of Oncology, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073787373","display_name":"Beno\u00eet You","orcid":"https://orcid.org/0000-0002-3177-8857","observed_orcids":["https://orcid.org/0000-0002-3177-8857"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4405260950","display_name":"Centre pour l'innovation en canc\u00e9rologie de Lyon","ror":"https://ror.org/04h6jac11","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264","https://openalex.org/I4405260950"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Benoit You","raw_affiliation_strings":["Early phase trial unit in oncology (CITOHL- EPSILYON), Centre pour l'lnnovation en Canc\u00e9rologie de Lyon (CICLY), Lyon University Hospital (HCL), Lyon, France; GINECO, Paris, France","Early phase trial unit in oncology (CITOHL- EPSILYON), Centre pour l'lnnovation en Canc\u00e9rologie de Lyon (CICLY), Lyon University Hospital (HCL), Lyon, France","GINECO, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early phase trial unit in oncology (CITOHL- EPSILYON), Centre pour l'lnnovation en Canc\u00e9rologie de Lyon (CICLY), Lyon University Hospital (HCL), Lyon, France; GINECO, Paris, France","institution_ids":["https://openalex.org/I4210100596","https://openalex.org/I4405260950"]},{"raw_affiliation_string":"Early phase trial unit in oncology (CITOHL- EPSILYON), Centre pour l'lnnovation en Canc\u00e9rologie de Lyon (CICLY), Lyon University Hospital (HCL), Lyon, France","institution_ids":["https://openalex.org/I4210100596","https://openalex.org/I4405260950"]},{"raw_affiliation_string":"GINECO, Paris, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":13,"institutions_distinct_count":28,"corresponding_author_ids":["https://openalex.org/A5062635658"],"corresponding_institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210094406","https://openalex.org/I4210158373"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":{"value":3800,"currency":"USD","value_usd":3800},"fwci":0.9697,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.75624772,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"35","issue":"7","first_page":"101863","last_page":"101863"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.7753999829292297,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.7753999829292297,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.21960000693798065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-ovarian-cancer","display_name":"advanced ovarian cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9819999933242798},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/treatment-decision-making","display_name":"treatment decision-making","score":0.6880000233650208},{"id":"https://openalex.org/keywords/patterns-of-care","display_name":"patterns of care","score":0.7710000276565552},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.7279999852180481},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9570000171661377},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.6589999794960022},{"id":"https://openalex.org/keywords/recist","display_name":"RECIST","score":0.6850000023841858},{"id":"https://openalex.org/keywords/tumor-mutational-status","display_name":"tumor mutational status","score":0.6460000276565552},{"id":"https://openalex.org/keywords/disease-progression-risk","display_name":"disease progression risk","score":0.7739999890327454},{"id":"https://openalex.org/keywords/figo-stage","display_name":"FIGO stage","score":0.5690000057220459},{"id":"https://openalex.org/keywords/cytoreduction","display_name":"cytoreduction","score":0.578000009059906},{"id":"https://openalex.org/keywords/expert-consensus","display_name":"expert consensus","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8660519123077393},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7304864525794983},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7029972076416016},{"id":"https://openalex.org/C60641444","wikidata":"https://www.wikidata.org/wiki/Q841602","display_name":"Delphi method","level":2,"score":0.5640970468521118},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5619492530822754},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5554425120353699},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.5001606941223145},{"id":"https://openalex.org/C2780194787","wikidata":"https://www.wikidata.org/wiki/Q4836333","display_name":"BRCA mutation","level":4,"score":0.49339166283607483},{"id":"https://openalex.org/C2780673598","wikidata":"https://www.wikidata.org/wiki/Q285223","display_name":"Genetic testing","level":2,"score":0.4837486743927002},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4756336212158203},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4099380373954773},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3892882466316223},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3782542943954468},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26241061091423035},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003697","descriptor_name":"Delphi Technique","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D060046","descriptor_name":"Maintenance Chemotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1136/ijgc-2024-005497","doi":"https://doi.org/10.1136/ijgc-2024-005497","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2024-005497","pdf_url":null,"source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"},{"id":"pmid:39448084","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39448084","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","raw_type":"Journal Article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:20.500.12942/754331","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/20.500.12942/754331","pdf_url":"https://lirias.kuleuven.be/retrieve/cd1eea97-9541-47b5-9549-e5d58e7e3afe","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal Of Gynecological Cancer, vol. 35 (7), Art.No. ARTN 101863","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.ed.ac.uk:openaire/d4fc8e29-0b50-4f05-a422-4afe5bf37d52","doi":null,"is_oa":true,"landing_page_url":"https://www.research.ed.ac.uk/files/477855588/ijgc-2024-005497.full.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400321","display_name":"Edinburgh Research Explorer (University of Edinburgh)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I98677209","host_organization_name":"University of Edinburgh","host_organization_lineage":["https://openalex.org/I98677209"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1136/ijgc-2024-005497","doi":"https://doi.org/10.1136/ijgc-2024-005497","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2024-005497","pdf_url":null,"source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8890405749","display_name":null,"funder_award_id":"CTIC-2021-002","funder_id":"https://openalex.org/F4320312041","funder_display_name":"Health Research Board"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320312041","display_name":"Health Research Board","ror":"https://ror.org/003hb2249"},{"id":"https://openalex.org/F4320324142","display_name":"European Society for Medical Oncology","ror":"https://ror.org/03xtz2n86"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403746293.pdf","grobid_xml":"https://content.openalex.org/works/W4403746293.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W1996361879","https://openalex.org/W2001403404","https://openalex.org/W2017265038","https://openalex.org/W2065635506","https://openalex.org/W2102306754","https://openalex.org/W2113122060","https://openalex.org/W2135947389","https://openalex.org/W2438866487","https://openalex.org/W2772844587","https://openalex.org/W2897430921","https://openalex.org/W2975141952","https://openalex.org/W2994977341","https://openalex.org/W3014984749","https://openalex.org/W3018077003","https://openalex.org/W3023274953","https://openalex.org/W3036597073","https://openalex.org/W3048693593","https://openalex.org/W3081630005","https://openalex.org/W3139553455","https://openalex.org/W3200484435","https://openalex.org/W3215585343","https://openalex.org/W4200234932","https://openalex.org/W4200326001","https://openalex.org/W4281686397","https://openalex.org/W4286561172","https://openalex.org/W4289134371","https://openalex.org/W4306661079","https://openalex.org/W4321180728","https://openalex.org/W4366979628","https://openalex.org/W4367845062","https://openalex.org/W4383814603","https://openalex.org/W4384120316","https://openalex.org/W4385951392","https://openalex.org/W4386306034","https://openalex.org/W4388452770","https://openalex.org/W4391447886","https://openalex.org/W4393935425"],"related_works":["https://openalex.org/W4387136077","https://openalex.org/W4381613276","https://openalex.org/W4283025800","https://openalex.org/W4389953889","https://openalex.org/W3041908485","https://openalex.org/W4321639156","https://openalex.org/W4412391108","https://openalex.org/W3125021412","https://openalex.org/W4237173156","https://openalex.org/W4364859914"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Maintenance":[1],"therapies,":[2],"including":[3],"poly":[4],"(ADP-ribose)":[5],"polymerase":[6],"(PARP)":[7],"inhibitors":[8],"and/or":[9],"bevacizumab,":[10,211],"have":[11],"substantially":[12],"improved":[13],"the":[14,24,41,99,245],"prognosis":[15],"of":[16,43,89,98,180,199,206,244],"patients":[17,74],"with":[18,75,191],"advanced":[19,55,76,220,228],"ovarian":[20,56,77,221,229],"cancer.":[21,57,78,222],"Owing":[22],"to":[23,39,65],"variability":[25],"in":[26,73,116,152,214,219],"treatment":[27,52,71],"strategies":[28,72],"across":[29],"Europe,":[30],"a":[31,80,87,93,131,203,238],"Delphi":[32,81],"study":[33],"was":[34,63,84,130,202],"conducted":[35,64],"among":[36,86],"European":[37],"experts":[38,91],"understand":[40],"heterogeneity":[42],"clinical":[44],"practice":[45],"and":[46,109,120,156,169,182,241],"identify":[47,66],"key":[48,67,204,239],"factors":[49],"driving":[50],"maintenance":[51,70,217,231],"decisions":[53],"for":[54,226,247],"METHODS:":[58],"A":[59],"pragmatic":[60,100],"literature":[61,101],"review":[62],"questions":[68],"regarding":[69],"Utilizing":[79],"methodology,":[82],"consensus":[83,132],"assessed":[85,115],"panel":[88],"16":[90],"using":[92],"questionnaire":[94],"based":[95],"on":[96],"results":[97],"review.":[102],"RESULTS:":[103],"Panelists":[104,146,173],"agreed":[105,147],"that":[106,121,133,148],"BRCA":[107],"mutation":[108],"homologous":[110,135],"recombination":[111,136],"status":[112,236],"should":[113],"be":[114,126],"parallel":[117],"at":[118],"diagnosis,":[119],"first-line":[122],"platinum":[123],"chemotherapy":[124],"may":[125],"initiated":[127],"concurrently.":[128],"There":[129],"alternative":[134],"deficiency":[137],"tests":[138],"are":[139,143],"acceptable":[140],"provided":[141],"they":[142],"clinically":[144],"validated.":[145],"Response":[149],"Evaluation":[150],"Criteria":[151],"Solid":[153],"Tumors":[154],"(RECIST)":[155],"CA-125":[157],"elimination":[158],"rate":[159],"constant":[160],"K":[161],"(KELIM)":[162],"scores":[163],"can":[164],"help":[165],"assess":[166],"tumor":[167,234],"chemosensitivity":[168],"guide":[170],"treatment-related":[171],"decisions.":[172],"defined":[174],"high-risk":[175],"disease":[176,187,193,200,249],"as":[177,216,237],"International":[178],"Federation":[179],"Gynecology":[181],"Obstetrics":[183],"(FIGO)":[184],"stage":[185,189],"IV":[186],"or":[188,212],"III":[190],"residual":[192],"after":[194],"initial/":[195],"interval":[196],"cytoreduction.":[197],"Risk":[198],"progression":[201],"determinant":[205],"choice":[207],"between":[208],"PARP":[209],"inhibitor,":[210],"both":[213],"combination,":[215],"therapy":[218],"CONCLUSIONS:":[223],"Key":[224],"drivers":[225],"selecting":[227],"cancer":[230],"treatments":[232],"include":[233],"mutational":[235],"biomarker":[240],"clinician":[242],"perception":[243],"risk":[246],"early":[248],"progression.":[250]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2024-10-25T00:00:00"}